• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪肝患者受控衰减参数与超声检查肝脂肪变程度的相关性:一项多中心回顾性队列研究。

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.

机构信息

Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2020 Nov;35(6):1346-1353. doi: 10.3904/kjim.2018.309. Epub 2019 Nov 8.

DOI:10.3904/kjim.2018.309
PMID:31694366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7652655/
Abstract

BACKGROUND/AIMS: The controlled attenuation parameter (CAP), based on transient elastography, is widely used for noninvasive assessment of the degree of hepatic steatosis (HS). We investigated the correlation of the degree HS between CAP and ultrasound (US) in patients with HS.

METHODS

In total, 986 patients with US-based HS who underwent transient elastography within 1 month were evaluated. The US-based grade of HS was categorized as mild (grade 1), moderate (grade 2), or severe (grade 3).

RESULTS

The CAP was significantly correlated with the US-based grade of HS (r = 0.458, p < 0.001). The median CAP value of each US-based HS grade showed a positive correlation with grade (271.1, 303.7, and 326.7 dB/m for grades 1, 2, and 3). In a multivariate analysis, the US-based HS grade, body mass index, serum albumin, alanine aminotransferase, and total cholesterol, and liver stiffness were all significantly correlated with the CAP value (all p < 0.05). The areas under the receiver operating characteristic curves for grade 2 to 3 and grade 3 HS were 0.749 (95% confidence interval [CI], 0.714 to 0.784) and 0.738 (95% CI, 0.704 to 0.772). The optimal cut-off CAP values to maximize the sum of the sensitivity and specificity for grade 2 to 3 and grade 3 HS were 284.5 dB/m (sensitivity 78.6%, specificity 61.7%) and 298.5 dB/m (sensitivity 84.6%, specificity 55.6%).

CONCLUSION

The correlation of the degree of HS between CAP and US was significantly high in patients with HS, and the optimal cut-off CAP values for grade 2 to 3 and grade 3 HS were 284.5 and 298.5 dB/m.

摘要

背景/目的:基于瞬时弹性成像的受控衰减参数(CAP)广泛用于非侵入性评估肝脂肪变性(HS)的程度。我们研究了 CAP 与 HS 患者 US 基础 HS 程度之间的相关性。

方法

共评估了 986 例在 1 个月内接受瞬时弹性成像检查的基于 US 的 HS 患者。基于 US 的 HS 分级分为轻度(1 级)、中度(2 级)或重度(3 级)。

结果

CAP 与基于 US 的 HS 分级显著相关(r=0.458,p<0.001)。每个基于 US 的 HS 分级的 CAP 值中位数与分级呈正相关(1 级、2 级和 3 级分别为 271.1、303.7 和 326.7 dB/m)。多元分析显示,基于 US 的 HS 分级、体重指数、血清白蛋白、丙氨酸氨基转移酶、总胆固醇和肝硬度均与 CAP 值显著相关(均 p<0.05)。2 级至 3 级和 3 级 HS 的受试者工作特征曲线下面积分别为 0.749(95%可信区间,0.714 至 0.784)和 0.738(95%可信区间,0.704 至 0.772)。为了最大限度地提高 2 级至 3 级和 3 级 HS 的敏感性和特异性之和,最佳的 CAP 截断值分别为 284.5 dB/m(敏感性 78.6%,特异性 61.7%)和 298.5 dB/m(敏感性 84.6%,特异性 55.6%)。

结论

HS 患者 CAP 与 US 基础 HS 程度之间的相关性显著较高,2 级至 3 级和 3 级 HS 的最佳 CAP 截断值分别为 284.5 和 298.5 dB/m。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d8/7652655/6ed408ae6a34/kjim-2018-309f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d8/7652655/fdaf3b5a900d/kjim-2018-309f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d8/7652655/6ed408ae6a34/kjim-2018-309f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d8/7652655/fdaf3b5a900d/kjim-2018-309f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d8/7652655/6ed408ae6a34/kjim-2018-309f2.jpg

相似文献

1
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.脂肪肝患者受控衰减参数与超声检查肝脂肪变程度的相关性:一项多中心回顾性队列研究。
Korean J Intern Med. 2020 Nov;35(6):1346-1353. doi: 10.3904/kjim.2018.309. Epub 2019 Nov 8.
2
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.受控衰减参数(CAP):基于瞬时弹性成像的肝脂肪变性非侵入性检测方法。
Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.
3
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.中国患者肝脏脂肪变性非侵入性评估的受控衰减参数
World J Gastroenterol. 2014 Apr 28;20(16):4702-11. doi: 10.3748/wjg.v20.i16.4702.
4
How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.在普通人群中,控制衰减参数和脂肪肝指数评估肝脂肪变性的效果如何:与超声的相关性
Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.
5
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.在晚期慢性肝脏疾病和门静脉高压症患者中,控制衰减参数的性能。
Dig Dis Sci. 2019 Dec;64(12):3642-3651. doi: 10.1007/s10620-019-05702-7. Epub 2019 Jun 17.
6
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病中肝脂肪变性检测和定量的受控衰减参数
J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.
7
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.使用受控衰减参数(CAP)和瞬时弹性成像技术进行非侵入性诊断肝脂肪变性。
Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
8
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.控制衰减参数(CAP)在慢性肝病患者肝脂肪变性检测中的应用:一项对韩国本地人群的前瞻性研究。
Liver Int. 2014 Jan;34(1):102-9. doi: 10.1111/liv.12282. Epub 2013 Sep 13.
9
Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter.通过受控衰减参数预测活体肝供者的肝脂肪变性
Transplant Proc. 2018 Dec;50(10):3533-3538. doi: 10.1016/j.transproceed.2018.06.039. Epub 2018 Jun 30.
10
Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.新型肝脂肪变无创评估的受控衰减参数检测可靠性标准。
United European Gastroenterol J. 2020 Apr;8(3):321-331. doi: 10.1177/2050640619900820. Epub 2020 Jan 17.

引用本文的文献

1
NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease.NLRP3 炎性小体通路参与代谢相关脂肪性肝病的发病机制。
Sci Rep. 2024 Aug 23;14(1):19648. doi: 10.1038/s41598-024-69764-y.
2
Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏脂肪含量的FibroScan测定
Cureus. 2021 Jul 15;13(7):e16414. doi: 10.7759/cureus.16414. eCollection 2021 Jul.

本文引用的文献

1
MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.受控衰减参数的测量:非酒精性脂肪性肝病患者生活方式改变时肝脂肪变性的替代标志物——一项前瞻性随访研究。
Arq Gastroenterol. 2018 Jan-Mar;55(1):7-13. doi: 10.1590/S0004-2803.201800000-07.
2
Management of patients with non-alcoholic steatohepatitis (NASH) in real life.非酒精性脂肪性肝炎(NASH)患者的真实生活管理。
Liver Int. 2018 Feb;38 Suppl 1:52-55. doi: 10.1111/liv.13637.
3
Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies.
非酒精性脂肪性肝病的自然史:一项采用系列活检的前瞻性随访研究。
Hepatol Commun. 2017 Dec 27;2(2):199-210. doi: 10.1002/hep4.1134. eCollection 2018 Feb.
4
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.非酒精性脂肪性肝病的影像学评估:重点在于定量分析。
Clin Mol Hepatol. 2017 Dec;23(4):290-301. doi: 10.3350/cmh.2017.0042. Epub 2017 Oct 10.
5
New trends on obesity and NAFLD in Asia.亚洲肥胖和非酒精性脂肪性肝病的新趋势。
J Hepatol. 2017 Oct;67(4):862-873. doi: 10.1016/j.jhep.2017.06.003. Epub 2017 Jun 19.
6
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.经瞬时弹性成像定义的非酒精性脂肪性肝病患者中显著纤维化的患病率及预测因素
Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18.
7
Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.使用受控衰减参数联合超声检查血液透析患者的非酒精性脂肪性肝病:一项前瞻性队列研究。
PLoS One. 2017 Apr 20;12(4):e0176027. doi: 10.1371/journal.pone.0176027. eCollection 2017.
8
Genetic predisposition in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的遗传易感性。
Clin Mol Hepatol. 2017 Mar;23(1):1-12. doi: 10.3350/cmh.2016.0109. Epub 2017 Mar 9.
9
Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.肥胖与通过瞬时弹性成像测量的肝脂肪变性和纤维化比代谢健康状况更为密切相关。
Metabolism. 2017 Jan;66:23-31. doi: 10.1016/j.metabol.2016.10.003. Epub 2016 Oct 15.
10
What we need to know when performing and interpreting US elastography.我们在进行和解读超声弹性成像时需要了解的内容。
Clin Mol Hepatol. 2016 Sep;22(3):406-414. doi: 10.3350/cmh.2016.0106.